Literature DB >> 16777457

Prospective survey on carriage of Neisseria meningitidis and protective immunity to meningococci in schoolchildren in Niamey (Niger): focus on serogroup W135.

Amina Amadou Hamidou1, Saacou Djibo, Ali Elhaj Mahamane, Amadou Moussa, Helen Findlow, Fati Sidikou, Rahamatou Cisse, Amadou Garba, Ray Borrow, Suzanne Chanteau, Pascal Boisier.   

Abstract

We investigated the carriage of serogroup W135 meningococci and its relationship with protective immunity in Niamey. Between February and May 2003, three oropharyngeal swabs and two serum samples were each taken from 287 school children. Serogroup W135 isolates were obtained from 8.9% of children. Specific IgG > or = 2 microg/ml using ELISA or serum bactericidal assay (SBA) titre > or = 8 were supposed to represent the protective immunity to a serogroup. The proportion of children with serogroup W135-specific IgG > or = 2 microg/ml increased significantly during follow-up (13.9% to 19.1%), but not the proportion of those with SBA titre > or = 8 (10.1% to 11.6%). At the end of the follow-up, we observed a significant association between carriage of serogroup W135 strains and presumed protective immunity to this serogroup, using either ELISA or SBA. Among 240 children having an initial SBA titre < 8, 20 carried serogroup W135 strains at least once. In May, 25% of carriers had an SBA titre > or = 8, vs. 2.3% of non-carriers. For ELISA, 230 children had specific IgG < 2 microg/ml in February, with 22 having at least one swab positive for serogroup W135 meningococci later. In May, 45.5% of them had specific IgG > or = 2 microg/ml vs. 5.3% among non-carriers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16777457     DOI: 10.1016/j.micinf.2006.03.006

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  6 in total

1.  Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.

Authors:  Paul A Kristiansen; Fabien Diomandé; Stanley C Wei; Rasmata Ouédraogo; Lassana Sangaré; Idrissa Sanou; Denis Kandolo; Pascal Kaboré; Thomas A Clark; Abdoul-Salam Ouédraogo; Ki Ba Absatou; Charles D Ouédraogo; Musa Hassan-King; Jennifer Dolan Thomas; Cynthia Hatcher; Mamoudou Djingarey; Nancy Messonnier; Marie-Pierre Préziosi; Marc LaForce; Dominique A Caugant
Journal:  Clin Vaccine Immunol       Date:  2011-01-12

2.  Seroprevalence of serum bactericidal antibodies against group W135 and Y meningococci in England in 2009.

Authors:  Caroline L Trotter; Helen Findlow; Ray Borrow
Journal:  Clin Vaccine Immunol       Date:  2011-12-21

3.  Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines.

Authors:  Peter T Beernink; Dan M Granoff
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

Review 4.  Incidence, carriage and case-carrier ratios for meningococcal meningitis in the African meningitis belt: a systematic review and meta-analysis.

Authors:  Thibaut Koutangni; Halima Boubacar Maïnassara; Judith E Mueller
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

5.  Meningococcal carriage by age in the African meningitis belt: a systematic review and meta-analysis.

Authors:  L V Cooper; P A Kristiansen; H Christensen; A Karachaliou; C L Trotter
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

6.  Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003.

Authors:  Judith E Mueller; Lassana Sangaré; Berthe-Marie Njanpop-Lafourcade; Zekiba Tarnagda; Yves Traoré; Seydou Yaro; Raymond Borrow; Bradford D Gessner; Pierre Nicolas
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.